Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperativ...

por Linge, Annett, Löck, Steffen, Krenn, Constanze, Appold, Steffen, Lohaus, Fabian, Nowak, Alexander, Gudziol, Volker, Baretton, Gustavo B., Buchholz, Frank, Baumann, Michael, Krause, Mechthild
Publicado 2016

Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy

por Linge, Annett, Schmidt, Stefan, Lohaus, Fabian, Krenn, Constanze, Bandurska-Luque, Anna, Platzek, Ivan, von Neubeck, Cläre, Appold, Steffen, Nowak, Alexander, Gudziol, Volker, Buchholz, Frank, Baretton, Gustavo B., Baumann, Michael, Löck, Steffen, Krause, Mechthild
Publicado 2019

A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT

por Patil, Shivaprasad, Linge, Annett, Hiepe, Hannah, Grosser, Marianne, Lohaus, Fabian, Gudziol, Volker, Kemper, Max, Nowak, Alexander, Haim, Dominik, Tinhofer, Inge, Budach, Volker, Guberina, Maja, Stuschke, Martin, Balermpas, Panagiotis, von der Grün, Jens, Schäfer, Henning, Grosu, Anca-Ligia, Abdollahi, Amir, Debus, Jürgen, Ganswindt, Ute, Belka, Claus, Pigorsch, Steffi, Combs, Stephanie E., Boeke, Simon, Zips, Daniel, Jöhrens, Korinna, Baretton, Gustavo B., Baumann, Michael, Krause, Mechthild, Löck, Steffen
Publicado 2022